MedTrace Logo

Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group

NCT04945603 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2023-11-29

No results posted yet for this study

Summary

Multicentric registry study in order to define outcome, predictors, treatment effects and their modifiers in poor grade aneurysmal subarachnoid haemorrhage patients.

The search for outcome predictors is going to be subdivided into three main research areas:

1. outcome predictors in the emergency department (so called "early brain injury phase").
2. outcome predictors in the neurocritical care unit (so called "delayed brain injury phase").
3. Treatment strategies. Two other areas of research are identified: delayed cerebral ischemia (incidence, treatment, predictors, impact on outcome) and long term follow-up (recent evidences suggest that there may be a non-negligible proportion of poor grade subarachnoid hemorrhage patients who may benefit from substantial improvement at long-term (after 6-12 months of follow-up).

Conditions

  • Subarachnoid Hemorrhage, Aneurysmal
  • Poor Grade Subarachnoid Hemorrhage

Interventions

OTHER

Standard management according to international/national guidelines

Standard management according to international/national guidelines. Observational study

Sponsors & Collaborators

  • Azienda Ospedaliera Universitaria Integrata Verona

    collaborator OTHER

  • Azienda Ospedaliero-Universitaria di Parma

    collaborator OTHER

  • Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

    collaborator OTHER

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    collaborator OTHER

  • A.O. Ospedale Papa Giovanni XXIII

    collaborator OTHER

  • ASL Taranto

    collaborator OTHER

  • Ospedale V. Fazzi

    collaborator OTHER

  • IRCCS Istituto delle Scienze Neurologiche di Bologna

    collaborator OTHER

  • Azienda Ospedaliero Universitaria Maggiore della Carita

    collaborator OTHER

  • IRCCS San Raffaele

    lead OTHER

Principal Investigators

  • Pietro Panni, P.I., M.D. · Department of Neuroradiology, Department of Neurosurgery

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-25
Primary Completion
2025-12-31
Completion
2028-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04945603 on ClinicalTrials.gov